NorthStar Medical Radioisotopes has finished construction of its new molybdenum-99 (Mo-99) processing facility in Beloit, WI, a milestone that moves the company closer to launching its second U.S. production hub for the isotope.
The 20,000-sq-ft facility will house Mo-99 dissolution and source vessel filling equipment, a quality control laboratory, an automated packaging line, and a molybdenum recycling complex, according to the vendor. NorthStar said that the facility -- after receiving appropriate licensure and U.S. Food and Drug Administration (FDA) approval -- will augment current processing of Mo-99 being performed with the company's partners at the University of Missouri Research Reactor.
